# Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

> **NCT04214834** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program** · enrollment: 189 (actual)

## Conditions studied

- Neonatal Opioid Withdrawal Syndrome

## Interventions

- **DRUG:** Morphine
- **DRUG:** Methadone

## Key facts

- **NCT ID:** NCT04214834
- **Lead sponsor:** Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-09-28
- **Primary completion:** 2024-01-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 189 (ACTUAL)
- **Last updated:** 2025-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04214834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04214834, "Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04214834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*